Journal article
Toll-like receptor 3 is a therapeutic target for pulmonary hypertension
- Abstract:
- Rationale: Pulmonary arterial hypertension (PAH) is characterized by vascular cell proliferation and endothelial cell apoptosis. Toll-like receptor 3 (TLR3) is a receptor for double-stranded RNA and has been recently implicated in vascular protection. Objective: The goal was to study the expression and role of TLR3 in PAH and to determine whether a TLR3 agonist reduces Pulmonary Hypertension in preclinical models. Methods: Lung tissue and endothelial cells from PAH patients were investigated by polymerase chain reaction, immunofluorescence and apoptosis assays. TLR3-/- and TLR3+/+ mice were exposed to chronic hypoxia and SU5416. Chronic hypoxia or chronic hypoxia/SU5416 rats were treated with the TLR3 agonist polyinosinic:polycytidylic acid [Poly(I:C)]. Measurements and Main Results: TLR3 expression was reduced in PAH patient lung tissue and endothelial cells, and TLR3-/- mice exhibited more severe Pulmonary Hypertension following exposure to chronic hypoxia/SU5416. TLR3 knockdown promoted double-stranded RNA signaling via other intracellular RNA receptors in endothelial cells and this was associated with greater susceptibility to apoptosis, a known driver of pulmonary vascular remodeling. Poly(I:C) increased TLR3 expression via interleukin-10 in rat endothelial cells. In vivo, high dose Poly(I:C) reduced Pulmonary Hypertension in both rat models in proof-of-principle experiments. In addition, Poly(I:C) also reduced right ventricular failure in established Pulmonary Hypertension. Conclusions: Our work identifies a novel role for TLR3 in PAH based on the findings that reduced expression of TLR3 contributes to endothelial apoptosis and pulmonary vascular remodeling.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 3.8MB, Terms of use)
-
- Publisher copy:
- 10.1164/rccm.201707-1370OC
Authors
- Publisher:
- American Thoracic Society
- Journal:
- American Journal of Respiratory and Critical Care Medicine More from this journal
- Volume:
- 199
- Issue:
- 2
- Pages:
- 199–210
- Publication date:
- 2018-09-13
- Acceptance date:
- 2018-07-03
- DOI:
- EISSN:
-
1535-4970
- ISSN:
-
1073-449X
- Keywords:
- Pubs id:
-
pubs:909584
- UUID:
-
uuid:f799795e-53b0-49c7-9875-f47dba6848d4
- Local pid:
-
pubs:909584
- Source identifiers:
-
909584
- Deposit date:
-
2018-08-23
- ARK identifier:
Terms of use
- Copyright holder:
- American Thoracic Society
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 by the American Thoracic Society. This is the accepted manuscript version of the article. The final version is available online from the American Thoracic Society at: https://doi.org/10.1164/rccm.201707-1370OC
If you are the owner of this record, you can report an update to it here: Report update to this record